ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,964
Screening encounters
3,367
Diagnostic referrals
643
Outstanding pathways
241

Screening pathway

  1. Screening3,367Encounters
  2. Positive finding1,159Documented findings
  3. Referral643Diagnostic referrals
  4. Follow-up758Diagnostic visits
  5. Outcome402Resolved pathways

Stage totals use different units. Pending pathways: 241. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2026-06-15, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22
  4. · Screening · HPV DNA · Repeat · Prior HPV positive
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Diagnostic referral · EXP-1908-T-R
  7. · Contact attempt · Unsuccessful
  8. · Diagnostic booking · Initial booking
  9. · Contact attempt · Reached
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-05-19
  14. · Follow-up disposition · Resolved · EXP-1908-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2964 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4809 · Expanded synthetic participant 4809Site C — Rural Outreach Programme
EXP-4812 · Expanded synthetic participant 4812Site C — Rural Outreach Programme
EXP-4813 · Expanded synthetic participant 4813Site B — Peri-Urban Access Programme
EXP-4814 · Expanded synthetic participant 4814Site E — Resource-Constrained Navigation Programme
EXP-4817 · Expanded synthetic participant 4817Site A — Urban Referral Hub
EXP-4818 · Expanded synthetic participant 4818Site D — Community Engagement Programme
EXP-4819 · Expanded synthetic participant 4819Site A — Urban Referral Hub
EXP-4820 · Expanded synthetic participant 4820Site A — Urban Referral Hub
EXP-4822 · Expanded synthetic participant 4822Site D — Community Engagement Programme
EXP-4824 · Expanded synthetic participant 4824Site B — Peri-Urban Access Programme
EXP-4826 · Expanded synthetic participant 4826Site D — Community Engagement Programme
EXP-4830 · Expanded synthetic participant 4830Site E — Resource-Constrained Navigation Programme
EXP-4831 · Expanded synthetic participant 4831Site E — Resource-Constrained Navigation Programme
EXP-4832 · Expanded synthetic participant 4832Site A — Urban Referral Hub
EXP-4833 · Expanded synthetic participant 4833Site C — Rural Outreach Programme
EXP-4835 · Expanded synthetic participant 4835Site E — Resource-Constrained Navigation Programme
EXP-4837 · Expanded synthetic participant 4837Site D — Community Engagement Programme
EXP-4842 · Expanded synthetic participant 4842Site B — Peri-Urban Access Programme
EXP-4843 · Expanded synthetic participant 4843Site E — Resource-Constrained Navigation Programme
EXP-4844 · Expanded synthetic participant 4844Site A — Urban Referral Hub
EXP-4847 · Expanded synthetic participant 4847Site A — Urban Referral Hub
EXP-4849 · Expanded synthetic participant 4849Site B — Peri-Urban Access Programme
EXP-4851 · Expanded synthetic participant 4851Site B — Peri-Urban Access Programme
EXP-4852 · Expanded synthetic participant 4852Site E — Resource-Constrained Navigation Programme
EXP-4853 · Expanded synthetic participant 4853Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1352
HPV DNA
1519
Cytology
496

Navigation activity

Barrier documented
549
Contact attempt
945
Navigation intervention
237
Diagnostic booking
796
Diagnostic visit
758

Documented barriers

Contact difficulty
181
Transport difficulty
169
Appointment coordination
199

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.